Needham analyst David Saxon raised the firm’s price target on Dentsply Sirona (XRAY) to $25 from $23 and keeps a Buy rating on the shares ahead of its Q4 results next month. The company is tracking below its 2026 EPS target of $3, but the management is expected to provide an update to its long range plan on the Q4 call, the analyst tells investors in a research note. Needham adds that it is rolling forward its valuation model to 2026 estimates in raising its price target
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XRAY:
- XRAY Lawsuit Alert! Class Action Against Dentsply Sirona Inc. (NASDAQ:XRAY)
- Netflix upgraded, Electronic Arts downgraded: Wall Street’s top analyst calls
- Dentsply Sirona downgraded to Hold from Buy at Jefferies
- Dentsply pivoting approach to Byte ‘seems logical,’ says Evercore ISI
- DENTSPLY SIRONA Discusses Byte Strategy at Conference